UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Post‐COVID‐19 hair loss: prevalence and associated factors among 5,891 patients

International journal of dermatology, 2022-05, Vol.61 (5), p.e162-e164

2022

Volltextzugriff (PDF)

Female-pattern hair loss: therapeutic update

Anais brasileiros de dermatología, 2023-07, Vol.98 (4), p.506-519

2023

Volltextzugriff (PDF)

Low-dose oral minoxidil for persistent chemotherapy and radiotherapy-induced alopecia in a pediatric female patient

Anais brasileiros de dermatología, 2024-07, Vol.99 (4), p.635-637

2024

Volltextzugriff (PDF)

Trends of the main bibliometric indicators of Anais Brasileiros de Dermatologia (2010–2019)

Anais brasileiros de dermatología, 2021-05, Vol.96 (3), p.309-314

2021

Volltextzugriff (PDF)

Folliculitis decalvans in women: A retrospective multicentre study of 150 patients

Journal of the European Academy of Dermatology and Venereology, 2024-01, Vol.38 (1), p.e66-e70

2024

Volltextzugriff (PDF)

Comparison of the hair shafts count between a manual and a customized method

Skin research and technology, 2020-11, Vol.26 (6), p.949-950

2020

Volltextzugriff (PDF)

American tegumentary leishmaniasis: severe side effects of pentavalent antimonial in a patient with chronic renal failure

Anais brasileiros de dermatología, 2019-05, Vol.94 (3), p.355-357

2019

Volltextzugriff (PDF)

Exuberant tufted folliculitis

Anais brasileiros de dermatología, 2019-01, Vol.94 (1), p.115-116

2019

Volltextzugriff (PDF)

Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial

JAMA dermatology (Chicago, Ill.), 2024-06, Vol.160 (6), p.600

2024

Volltextzugriff (PDF)

Prevalence of female pattern hair loss in a multiracial population

Journal of the American Academy of Dermatology, 2022-04, Vol.86 (4), p.962-964

2022

Volltextzugriff (PDF)

Female Pattern Hair Loss: a clinical and pathophysiological review

Anais brasileiros de dermatología, 2015-07, Vol.90 (4), p.529-543

2015

Volltextzugriff (PDF)

Alopecia and grey hair are associated with COVID‐19 Severity

Experimental dermatology, 2020-12, Vol.29 (12), p.1250-1252

2020

Volltextzugriff (PDF)

Pattern hair loss: Assessment of microinflammation in miniaturized and terminal hair follicles through horizontal histologic sections

Journal of the American Academy of Dermatology, 2020-08, Vol.83 (2), p.e145-e146

2020

Volltextzugriff (PDF)

Trends in bibliometric indexes of the main dermatology journals (2009 to 2019)

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.782-783

2021

Volltextzugriff (PDF)

Androgen sensitivity gateway to COVID‐19 disease severity

Drug development research, 2020-11, Vol.81 (7), p.771-776

2020

Volltextzugriff (PDF)

Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients

Journal of the American Academy of Dermatology, 2021-04, Vol.84 (4), p.1175-1178

2021

Volltextzugriff (PDF)

Prospective cardiovascular evaluation with 24-hour Holter and 24-hour ambulatory blood pressure monitoring in men using 5-mg oral minoxidil for androgenetic alopecia

Journal of the American Academy of Dermatology, 2023-02, Vol.88 (2), p.436-437

2023

Volltextzugriff (PDF)

Randomized clinical trial of low-dose oral minoxidil for the treatment of female pattern hair loss: 0.25 mg versus 1 mg

Journal of the American Academy of Dermatology, 2022-08, Vol.87 (2), p.396-399

2022

Volltextzugriff (PDF)

Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?

Journal of cosmetic dermatology, 2020-07, Vol.19 (7), p.1542-1543

2020

Volltextzugriff (PDF)

Response to Ong et al, “Hair-raising costs: Evaluating botulinum toxin treatment for androgenetic alopecia”

Journal of the American Academy of Dermatology, 2024-09

2024

Volltextzugriff (PDF)

Androgen sensitivity in COVID‐19 and antiandrogens: Prospective data are still needed

Dermatologic therapy, 2020-11, Vol.33 (6), p.e14166-n/a

2020

Volltextzugriff (PDF)

Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization

Journal of the American Academy of Dermatology, 2022-05, Vol.86 (5), p.e207-e208

2022

Volltextzugriff (PDF)

JAK-STAT pathway inhibitors in dermatology

Anais brasileiros de dermatología, 2023-09, Vol.98 (5), p.656-677

2023

Volltextzugriff (PDF)

Minimally invasive procedures for the management of female pattern hair loss

Journal of cosmetic dermatology, 2022-11, Vol.21 (11), p.5405-5408

2022

Volltextzugriff (PDF)

Oral minoxidil 7.5 mg for hair loss increases heart rate with no change in blood pressure in 24 h Holter and 24 h ambulatory blood pressure monitoring

Anais brasileiros de dermatología, 2024-09, Vol.99 (5), p.734-736

2024

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(102)

Publikationsform

Artikel
(107)
Berichte
(3)

Sprache

Englisch
(106)
Portugiesisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Post‐COVID‐19 hair loss: prevalence and associated factors among 5,891 patients

Female-pattern hair loss: therapeutic update

Low-dose oral minoxidil for persistent chemotherapy and radiotherapy-induced alopecia in a pediatric female patient

Trends of the main bibliometric indicators of Anais Brasileiros de Dermatologia (2010–2019)

Folliculitis decalvans in women: A retrospective multicentre study of 150 patients

Comparison of the hair shafts count between a manual and a customized method

American tegumentary leishmaniasis: severe side effects of pentavalent antimonial in a patient with chronic renal failure

Exuberant tufted folliculitis

Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial

Prevalence of female pattern hair loss in a multiracial population

Female Pattern Hair Loss: a clinical and pathophysiological review

Alopecia and grey hair are associated with COVID‐19 Severity

Pattern hair loss: Assessment of microinflammation in miniaturized and terminal hair follicles through horizontal histologic sections

Trends in bibliometric indexes of the main dermatology journals (2009 to 2019)

Androgen sensitivity gateway to COVID‐19 disease severity

Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients

Prospective cardiovascular evaluation with 24-hour Holter and 24-hour ambulatory blood pressure monitoring in men using 5-mg oral minoxidil for androgenetic alopecia

Randomized clinical trial of low-dose oral minoxidil for the treatment of female pattern hair loss: 0.25 mg versus 1 mg

Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?

Response to Ong et al, “Hair-raising costs: Evaluating botulinum toxin treatment for androgenetic alopecia”

Androgen sensitivity in COVID‐19 and antiandrogens: Prospective data are still needed

Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization

JAK-STAT pathway inhibitors in dermatology

Minimally invasive procedures for the management of female pattern hair loss

Oral minoxidil 7.5 mg for hair loss increases heart rate with no change in blood pressure in 24 h Holter and 24 h ambulatory blood pressure monitoring

Suchergebnisse filtern